CLOVIS ONCOLOGY INC shareholder history

Current and past CLOVIS ONCOLOGY INC shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
MACKAY SHIELDS LLC 18180.00%0.00%0.01%Q2 2018Q3 202218
MORGAN STANLEY 18180.00%0.00%0.00%Q2 2018Q3 202218
PALISADE CAPITAL MANAGEMENT, LP 18180.00%0.01%0.01%Q2 2018Q3 202218
BlackRock Inc. 18180.00%0.00%0.00%Q2 2018Q3 202218
AMERIPRISE FINANCIAL INC 18180.01%0.01%0.01%Q2 2018Q3 202218
Allianz Asset Management GmbH 17170.01%0.02%0.04%Q2 2018Q2 202217
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 17170.00%0.00%0.00%Q3 2018Q3 202217
FARALLON CAPITAL MANAGEMENT LLC 16160.06%0.17%0.26%Q4 2018Q3 202216
JPMORGAN CHASE & CO 1510.00%0.00%0.00%Q3 2018Q3 202216
D. E. Shaw & Co., Inc. 16160.01%0.02%0.02%Q4 2018Q3 202216
CITIGROUP INC 16160.00%0.00%0.01%Q4 2018Q3 202216
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1410.13%0.79%1.84%Q4 2018Q4 202215
UBS OCONNOR LLC 1110.13%0.33%0.57%Q4 2018Q3 202214
CREDIT SUISSE AG/ 14140.00%0.00%0.01%Q2 2018Q3 202114
Antara Capital LP 1220.07%2.53%4.81%Q4 2018Q3 202214
WELLS FARGO & COMPANY/MN 1120.00%0.00%0.00%Q2 2018Q3 202213
DEUTSCHE BANK AG\ 13130.00%0.00%0.00%Q2 2018Q2 202113
CAPSTONE INVESTMENT ADVISORS, LLC 11110.02%0.05%0.10%Q2 2018Q4 202011
Citadel Advisors 770.00%0.00%0.01%Q4 2018Q2 20207
CSS LLC/IL 430.03%0.09%0.21%Q1 2019Q4 20207
AQR Arbitrage LLC 770.05%0.07%0.11%Q2 2018Q4 20197
Bank of New York Mellon Corp 660.00%0.00%0.00%Q2 2018Q3 20196
CAMDEN ASSET MANAGEMENT L P /CA 660.07%0.36%0.70%Q2 2018Q3 20196
NOMURA HOLDINGS INC 420.00%0.00%0.00%Q2 2018Q2 20206
FRANKLIN RESOURCES INC 660.01%0.01%0.02%Q2 2018Q3 20196
MOORE CAPITAL MANAGEMENT, LP 660.02%0.03%0.04%Q2 2018Q3 20196
BANK OF AMERICA CORP /DE/ 660.00%0.00%0.00%Q2 2018Q3 20196
ADVENT CAPITAL MANAGEMENT /DE/ 550.06%0.15%0.45%Q2 2018Q2 20195
ARISTEIA CAPITAL, L.L.C. 550.03%0.34%1.19%Q4 2019Q4 20205
Castle Creek Arbitrage, LLC 550.15%0.34%0.49%Q2 2019Q2 20205
Empyrean Capital Partners, LP 550.15%0.23%0.30%Q3 2019Q3 20205
MIZUHO SECURITIES USA LLC 550.03%0.14%0.23%Q3 2018Q3 20195
SG Americas Securities, LLC 550.01%0.01%0.02%Q2 2018Q2 20195
Psagot Value Holdings Ltd. 440.01%0.06%0.17%Q4 2020Q3 20214
PUTNAM INVESTMENTS LLC 440.01%0.01%0.02%Q2 2018Q1 20194
PointState Capital LP 440.09%0.17%0.33%Q2 2018Q1 20194
PFM Health Sciences, LP 210.22%0.52%0.69%Q2 2018Q1 20193
ARROWGRASS CAPITAL PARTNERS (US) LP 330.04%0.13%0.19%Q4 2018Q2 20193
Psagot Value Holdings Ltd. / (Israel) 330.07%0.11%0.17%Q3 2021Q1 20223
BNP Paribas Asset Management Holding S.A. 330.00%0.00%0.01%Q1 2019Q3 20193
Partner Investment Management, L.P. 210.10%0.30%0.46%Q2 2018Q1 20193
Jabre Capital Partners S.A. 330.19%3.42%9.18%Q2 2018Q4 20183
EDMOND DE ROTHSCHILD HOLDING S.A. 220.04%0.05%0.05%Q2 2018Q3 20182
OAKTREE CAPITAL MANAGEMENT LP 220.05%0.06%0.07%Q1 2021Q2 20212
SSI INVESTMENT MANAGEMENT LLC 220.18%0.20%0.23%Q2 2018Q3 20182
SHENKMAN CAPITAL MANAGEMENT INC 220.82%0.90%0.98%Q2 2018Q3 20182
AMUNDI ASSET MANAGEMENT US, INC. 220.00%0.04%0.08%Q2 2018Q3 20182
Nicholas Investment Partners, LP 220.07%0.07%0.08%Q4 2018Q1 20192
Context Capital Management, LLC 110.60%0.69%0.79%Q2 2018Q4 20182
KINGDON CAPITAL MANAGEMENT, L.L.C. 220.11%0.15%0.19%Q2 2018Q3 20182
Shaolin Capital Management LLC 220.25%0.28%0.32%Q3 2019Q4 20192
SYMPHONY ASSET MANAGEMENT LLC 220.10%0.16%0.21%Q3 2018Q4 20182
Soros Fund Management 220.09%0.13%0.17%Q3 2019Q4 20192
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 110.00%0.00%0.00%Q2 2018Q2 20181
BANK OF MONTREAL /CAN/ 110.00%0.00%0.00%Q2 2021Q2 20211
MRCap LP 113.11%3.11%3.11%Q1 2019Q1 20191
WHITEBOX ADVISORS LLC 110.02%0.02%0.02%Q4 2019Q4 20191
JANE STREET GROUP, LLC 110.00%0.00%0.00%Q2 2018Q2 20181
QCM Cayman, Ltd. 111.22%1.22%1.22%Q4 2018Q4 20181
Russell Investments Group, Ltd. 110.00%0.00%0.00%Q2 2021Q2 20211
Monashee Investment Management LLC 110.09%0.09%0.09%Q2 2018Q2 20181
LINDEN ADVISORS LP 110.10%0.10%0.10%Q2 2018Q2 20181
Opti Capital Management, LP 110.42%0.42%0.42%Q2 2019Q2 20191
BlueCrest Capital Management Ltd 110.08%0.08%0.08%Q2 2018Q2 20181

This page lists all the filers that currently own CLOVIS ONCOLOGY INC or have owned CLOVIS ONCOLOGY INC in the past.